Govt to decriminalise 1,000 minor offences, overhaul IP regime

New Delhi:  The Government will identify 1,000 provisions penalising minor offences within the next 45 days for decriminalisation, commerce and industry minister Piyush Goyal said on Wednesday.

He also invited stakeholder inputs for a review of various laws governing intellectual property (IP) to simplify and make them more user-friendly. Based on the feedback, the government may amend existing laws or introduce new ones, as was done with the new Income Tax Bill.

The initiative aims to make India’s IP framework more innovation-friendly while ensuring affordability and access to medicines.

“We are focused on data exclusivity, but without evergreening creeping into our system,” Goyal told IP stakeholders, warning that patent evergreening could result in costly medicines and invite retaliatory taxes from other countries.

Goyal described data exclusivity as the “last missing link” before India could attract significant R&D inflows. He noted that two of the most dissatisfied stakeholders with India’s patent laws – Switzerland and the UK – have already completed an IP chapter with India in ongoing trade negotiations.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre